A Study of GIC-102 (Allogeneic Natural Killer Cells) in Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, and Multiple Myeloma

Conditions:   Advanced Solid Tumors;   Relapsed/Refractory Non-Hodgkin Lymphoma;   Relapsed/Refractory Multiple Myeloma Intervention:   Biological: GIC-102 (Allogeneic NK cells) Sponsor:   GI Cell, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials